Published in J Clin Virol on August 01, 2002
Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids. J Virol (2003) 1.08
Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother (2010) 0.99
Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol (2010) 0.88
Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain. Antimicrob Agents Chemother (2005) 0.83
The pre-NH(2)-terminal domain of the herpes simplex virus 1 DNA polymerase catalytic subunit is required for efficient viral replication. J Virol (2012) 0.80
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients. Hepatology (2008) 3.14
Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART. Clin Infect Dis (2004) 1.68
Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis (2009) 1.67
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients. AIDS (2008) 1.50
HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. Metabolism (2006) 1.26
Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Aust N Z J Psychiatry (2003) 1.17
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. AIDS (2003) 1.15
An outbreak of necrotizing enterocolitis associated with norovirus genotype GII.3. Pediatr Infect Dis J (2010) 1.14
Melting muscles: novel H1N1 influenza A associated rhabdomyolysis. Pediatr Infect Dis J (2009) 1.09
Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry (2005) 1.06
Studies of measles viruses circulating in Australia between 1999 and 2001 reveals a new genotype. Virus Res (2003) 1.05
Reduction in hospitalwide incidence of infection or colonization with methicillin-resistant Staphylococcus aureus with use of antimicrobial hand-hygiene gel and statistical process control charts. Infect Control Hosp Epidemiol (2007) 1.01
Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS. Sex Health (2007) 1.00
Testing rates for sexually transmitted infections among HIV-infected men who have sex with men attending two different HIV services. Int J STD AIDS (2008) 0.96
Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression. J Acquir Immune Defic Syndr (2009) 0.92
Reality check of laboratory service effectiveness during pandemic (H1N1) 2009, Victoria, Australia. Emerg Infect Dis (2011) 0.88
Novel measles virus genotype, East Timor and Australia. Emerg Infect Dis (2002) 0.88
Analysis of HIV-1 viral load in seminal plasma samples. J Clin Virol (2003) 0.86
HIV replication is associated with increased severity of liver biopsy changes in HIV-HBV and HIV-HCV co-infection. J Med Virol (2012) 0.84
Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART. J Int Assoc Physicians AIDS Care (Chic) (2007) 0.84
Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial. AIDS (2009) 0.83
High levels of psychological distress in MSM are independent of HIV status. J Health Psychol (2011) 0.83
The prevalence and risk behaviours associated with the transmission of blood-borne viruses among ethnic-Vietnamese injecting drug users. Aust N Z J Public Health (2006) 0.82
The cognitive fusion questionnaire: a preliminary study of psychometric properties and prediction of functioning in chronic pain. Clin J Pain (2014) 0.80
Measles with a possible 23 day incubation period. Commun Dis Intell Q Rep (2012) 0.78
Virological significance, prevalence and genetic basis of hypersusceptibility to nonnucleoside reverse transcriptase inhibitors. Sex Health (2004) 0.78
Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon. Clin Infect Dis (2007) 0.77
Hepatitis C in psychiatry inpatients: testing rates, prevalence and risk behaviours. Australas Psychiatry (2007) 0.77
Letter regarding Mycobacterium ulcerans. Ann Plast Surg (2007) 0.75
Introducing assessments to new medical students: a transition workshop. Med Educ (2003) 0.75
Skeletal myopathy associated with nucleoside reverse transcriptase inhibitor therapy: potential benefit of coenzyme Q10 therapy. Int J STD AIDS (2005) 0.75
Assisted reproduction for HIV-infected couples. Sex Health (2005) 0.75
Interpreting positive cultures of endotracheal aspirates: factors associated with treatment decisions in ventilated neonates. J Paediatr Child Health (2011) 0.75
Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy. AIDS (2017) 0.75
Efavirenz-induced catatonia. AIDS (2002) 0.75
Microfluidic enzymatic DNA extraction on a hybrid polyester-toner-PMMA device. Analyst (2016) 0.75